血清SII、TyG、FAR与急性心肌梗死患者冠脉病变严重程度的相关性研究综述
A Review of the Correlation between Serum SII, TyG, FAR and the Severity of Coronary Lesions in Patients with Acute Myocardial Infarction
摘要: 心血管疾病(cardiovascular disease, CVD)是全球发病率和死亡率的主要原因,严重威胁着全球人类的健康。CVD包含疾病有多种其中急性心肌梗死(AMI)是最常见严重危害中老年人群健康的心血管疾病之一,血清甘油三酯葡萄糖指数(triglyceride-glucose index, TyG指数)是胰岛素抵抗(insulin resistance, IR)的一种新型替代指标,为条件受限地区临床决策提供有力依据。有研究指出TyG指数不仅可预测CVD、2型糖尿病的发生发展,还可评估代谢性疾病发生。SII对冠心病患者介入治疗后发生不良心血管事件的预测价值优于传统危险。FAR在预测主要心血管不良事件尤其是合并DM方面比单独用FIB和Alb有更高敏感性和特异性。本文旨在阐述TyG指数与FIB/Alb比值(FAR)、SII在AMI患者中冠脉病变严重程度的发生发展关系,以便更好地了解TyG指数、FIB/Alb比值(FAR)、SII在AMI中的应用价值。
Abstract: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide and poses a serious threat to human health worldwide. CVD includes a variety of diseases, among which acute myocardial infarction (AMI) is one of the most common cardiovascular diseases that seriously harm the health of middle-aged and elderly people. Serum triglyceride-glucose index (TyG index) is a novel proxy for insulin resistance (IR), which provides a strong basis for clinical decision-making in restricted areas. Some studies have pointed out that TyG index can not only predict the occurrence and development of CVD and type 2 diabetes, but also evaluate the occurrence of metabolic diseases. The predictive value of SII for adverse cardiovascular events in patients with coronary heart disease after interventional therapy is better than that of traditional risk. FAR has higher sensitivity and specificity than FIB and Alb alone in predicting major cardiovascular adverse events, especially with DM. This paper aims to describe the relationship between TyG index, FIB/Alb ratio (FAR) and SII in the severity of coronary lesions in patients with AMI, so as to better understand the application value of TyG index, FIB/Alb ratio (FAR) and SII in AMI.
文章引用:高院, 高燕. 血清SII、TyG、FAR与急性心肌梗死患者冠脉病变严重程度的相关性研究综述[J]. 临床医学进展, 2025, 15(2): 1744-1753. https://doi.org/10.12677/acm.2025.152532

参考文献

[1] Yusuf, S., Joseph, P., Rangarajan, S., Islam, S., Mente, A., Hystad, P., et al. (2020) Modifiable Risk Factors, Cardiovascular Disease, and Mortality in 155 722 Individuals from 21 High-Income, Middle-Income, and Low-Income Countries (PURE): A Prospective Cohort Study. The Lancet, 395, 795-808. [Google Scholar] [CrossRef] [PubMed]
[2] 马丽媛, 王增武, 樊静, 等. 《中国心血管健康与疾病报告2021》概要[J]. 中国介入心脏病学杂志, 2022, 30(7): 481-496.
[3] Deedwania, P., Murphy, S.A., Scheen, A., Badariene, J., Pineda, A.L., Honarpour, N., et al. (2021) Efficacy and Safety of PCSK9 Inhibition with Evolocumab in Reducing Cardiovascular Events in Patients with Metabolic Syndrome Receiving Statin Therapy. JAMA Cardiology, 6, 139-147. [Google Scholar] [CrossRef] [PubMed]
[4] 陈才鸿, 杨阳, 乐兴丁, 等. HDL-C/ApoA1比值、TyG指数与急性非ST段抬高型心肌梗死患者冠状动脉病变严重程度的相关性[J]. 医学理论与实践, 2024, 37(17): 2986-2988.
[5] Tong, X., Zhang, Y., Yu, Z., Pu, S., Li, X., Xu, Y., et al. (2022) Triglyceride Glucose Index Is Related with the Risk of Mild Cognitive Impairment in Type 2 Diabetes. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 15, 3577-3587. [Google Scholar] [CrossRef] [PubMed]
[6] 柏继成, 廖清池, 李桃勇. 甘油三酯-葡萄糖指数在老年急性心肌梗死诊断中的应用价值[J]. 中国社区医师, 2024, 40(19): 94-96.
[7] 陈艳丽. 急性心肌梗死患者甘油三酯葡萄糖指数与冠脉病变严重程度的相关性研究[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2024.
[8] 王忠奇, 李今朝, 吴南. 急性冠脉综合征患者全身免疫炎症指数与冠状动脉病变严重程度的相关性[J]. 临床荟萃, 2024, 39(6): 512-517.
[9] Yapijakis, C., Bramos, A., Nixon, A.M., et al. (2012) The Interplay between Hemostasis and Malignancy: The Oral Cancer Paradigm. Anticancer Research, 32, 1791-1800.
[10] Casini, A., Neerman-Arbez, M. and de Moerloose, P. (2013) Congenital Fibrinogen Disorders: An Update. Seminars in Thrombosis and Hemostasis, 39, 585-595. [Google Scholar] [CrossRef] [PubMed]
[11] Fibrinogen Studies Collaboration, Danesh, J., Lewington, S., et al. (2005) Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality: An Individual Participant Meta-Analysis. Journal of the American Medical Association, 294, 1799-1809.
[12] 余亚仁, 李文华, 陈静, 等. 胆红素血脂综合指数和纤维蛋白原水平与冠状动脉病变程度的相关性研究[J]. 中国循环杂志, 2015(11): 1039-1042.
[13] 刘舒予, 于复超, 魏芹, 等. 纤维蛋白原/白蛋白比值与冠脉病变严重程度的相关性分析及其临床应用价值[J]. 解放军医学院学报, 2022, 43(5): 558-562+569.
[14] 朱海燕, 胡玲玲, 王静. 纤维蛋白原/白蛋白比值对于冠心病患者的诊断价值及其与冠状动脉病变严重程度的相关性[J]. 中国卫生检验杂志, 2021, 31(10): 1219-1222+1225.
[15] Son, D., Lee, H.S., Lee, Y., Lee, J. and Han, J. (2022) Comparison of Triglyceride-Glucose Index and HOMA-IR for Predicting Prevalence and Incidence of Metabolic Syndrome. Nutrition, Metabolism and Cardiovascular Diseases, 32, 596-604. [Google Scholar] [CrossRef] [PubMed]
[16] Tahapary, D.L., Pratisthita, L.B., Fitri, N.A., Marcella, C., Wafa, S., Kurniawan, F., et al. (2022) Challenges in the Diagnosis of Insulin Resistance: Focusing on the Role of HOMA-IR and Tryglyceride/Glucose Index. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 16, Article 102581. [Google Scholar] [CrossRef] [PubMed]
[17] Popa, C., Netea, M.G., van Riel, P.L.C.M., van der Meer, J.W.M. and Stalenhoef, A.F.H. (2007) The Role of TNF-Α in Chronic Inflammatory Conditions, Intermediary Metabolism, and Cardiovascular Risk. Journal of Lipid Research, 48, 751-762. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, M., Wang, B., Liu, Y., Sun, X., Luo, X., Wang, C., et al. (2017) Cumulative Increased Risk of Incident Type 2 Diabetes Mellitus with Increasing Triglyceride Glucose Index in Normal-Weight People: The Rural Chinese Cohort Study. Cardiovascular Diabetology, 16, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[19] Navarro-González, D., Sánchez-Íñigo, L., Pastrana-Delgado, J., Fernández-Montero, A. and Martinez, J.A. (2016) Triglyceride-Glucose Index (Tyg Index) in Comparison with Fasting Plasma Glucose Improved Diabetes Prediction in Patients with Normal Fasting Glucose: The Vascular-Metabolic CUN Cohort. Preventive Medicine, 86, 99-105. [Google Scholar] [CrossRef] [PubMed]
[20] Tanaka, A. and Node, K. (2022) Pathogenic Connection between Hypertension and Type 2 Diabetes: How Do They Mutually Affect Each Other? Hypertension Research, 45, 1840-1842. [Google Scholar] [CrossRef] [PubMed]
[21] Olsen, M.H., Angell, S.Y., Asma, S., Boutouyrie, P., Burger, D., Chirinos, J.A., et al. (2016) A Call to Action and a Life-Course Strategy to Address the Global Burden of Raised Blood Pressure on Current and Future Generations: The Lancet Commission on Hypertension. The Lancet, 388, 2665-2712. [Google Scholar] [CrossRef] [PubMed]
[22] Mao, Q., Zhou, D., Li, Y., Wang, Y., Xu, S. and Zhao, X. (2019) The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-St-Segment Elevation Acute Coronary Syndrome. Disease Markers, 2019, 1-11. [Google Scholar] [CrossRef] [PubMed]
[23] Zhao, Q., Zhang, T., Cheng, Y., Ma, Y., Xu, Y., Yang, J., et al. (2020) Impacts of Triglyceride-Glucose Index on Prognosis of Patients with Type 2 Diabetes Mellitus and Non-St-Segment Elevation Acute Coronary Syndrome: Results from an Observational Cohort Study in China. Cardiovascular Diabetology, 19, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
[24] Luo, E., Wang, D., Yan, G., Qiao, Y., Liu, B., Hou, J., et al. (2019) High Triglyceride-Glucose Index Is Associated with Poor Prognosis in Patients with Acute St-Elevation Myocardial Infarction after Percutaneous Coronary Intervention. Cardiovascular Diabetology, 18, Article No. 150. [Google Scholar] [CrossRef] [PubMed]
[25] Thai, P.V., Tien, H.A., Van Minh, H. and Valensi, P. (2020) Triglyceride Glucose Index for the Detection of Asymptomatic Coronary Artery Stenosis in Patients with Type 2 Diabetes. Cardiovascular Diabetology, 19, Article No. 137. [Google Scholar] [CrossRef] [PubMed]
[26] 刘晓彤. TyG指数对急性心肌梗死非糖尿病患者预后的预测价值[D]: [硕士学位论文]. 太原: 山西医科大学, 2023.
[27] Jin, J., Cao, Y., Wu, L., You, X., Guo, Y., Wu, N., et al. (2018) Triglyceride Glucose Index for Predicting Cardiovascular Outcomes in Patients with Coronary Artery Disease. Journal of Thoracic Disease, 10, 6137-6146. [Google Scholar] [CrossRef] [PubMed]
[28] Gao, A., Liu, J., Hu, C., Liu, Y., Zhu, Y., Han, H., et al. (2021) Association between the Triglyceride Glucose Index and Coronary Collateralization in Coronary Artery Disease Patients with Chronic Total Occlusion Lesions. Lipids in Health and Disease, 20, Article No. 140. [Google Scholar] [CrossRef] [PubMed]
[29] Jiang, Z., Zhu, J., Shen, H., Zhao, S., Tang, Y., Tang, S., et al. (2022) A High Triglyceride-Glucose Index Value Is Associated with an Increased Risk of Carotid Plaque Burden in Subjects with Prediabetes and New-Onset Type 2 Diabetes: A Real-World Study. Frontiers in Cardiovascular Medicine, 9, Article 832491. [Google Scholar] [CrossRef] [PubMed]
[30] Li, J., Dong, Z., Wu, H., Liu, Y., Chen, Y., Li, S., et al. (2023) The Triglyceride-Glucose Index Is Associated with Atherosclerosis in Patients with Symptomatic Coronary Artery Disease, Regardless of Diabetes Mellitus and Hyperlipidaemia. Cardiovascular Diabetology, 22, Article No. 224. [Google Scholar] [CrossRef] [PubMed]
[31] Ye, Z., Hu, T., Wang, J., Xiao, R., Liao, X., Liu, M., et al. (2022) Systemic Immune-Inflammation Index as a Potential Biomarker of Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine, 9, Article 933913. [Google Scholar] [CrossRef] [PubMed]
[32] Candemir, M., Kiziltunç, E., Nurkoç, S. and Şahinarslan, A. (2021) Relationship between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease. Angiology, 72, 575-581. [Google Scholar] [CrossRef] [PubMed]
[33] Liu, Y., Ye, T., Chen, L., Jin, T., Sheng, Y., Wu, G., et al. (2021) Systemic Immune-Inflammation Index Predicts the Severity of Coronary Stenosis in Patients with Coronary Heart Disease. Coronary Artery Disease, 32, 715-720. [Google Scholar] [CrossRef] [PubMed]
[34] Huang, J., Zhang, Q., Wang, R., Ji, H., Chen, Y., Quan, X., et al. (2019) Systemic Immune-Inflammatory Index Predicts Clinical Outcomes for Elderly Patients with Acute Myocardial Infarction Receiving Percutaneous Coronary Intervention. Medical Science Monitor, 25, 9690-9701. [Google Scholar] [CrossRef] [PubMed]
[35] 张世袍, 杨阳, 陈才鸿, 等. 系统免疫炎症指数、心外膜脂肪厚度与冠状动脉病变严重程度的相关性分析[J]. 医学理论与实践, 2024, 37(14): 2445-2447.
[36] 孙涛. 系统免疫炎症指数与老年冠心病患者不同糖代谢状态下冠状动脉病变严重程度的相关性研究[D]: [硕士学位论文]. 成都: 成都医学院, 2023.
[37] Lai, W., Zhao, X., Huang, Z., Xie, Y., Yu, S., Tu, J., et al. (2022) Elevation of Preprocedural Systemic Immune Inflammation Level Increases the Risk of Contrast-Associated Acute Kidney Injury Following Coronary Angiography: A Multicenter Cohort Study. Journal of Inflammation Research, 15, 2959-2969. [Google Scholar] [CrossRef] [PubMed]
[38] Dziedzic, E.A., Gąsior, J.S., Tuzimek, A., Dąbrowski, M. and Jankowski, P. (2022) The Association between Serum Vitamin D Concentration and New Inflammatory Biomarkers—Systemic Inflammatory Index (SII) and Systemic Inflammatory Response (SIRI)—In Patients with Ischemic Heart Disease. Nutrients, 14, Article 4212. [Google Scholar] [CrossRef] [PubMed]
[39] Gok, M. and Kurtul, A. (2020) A Novel Marker for Predicting Severity of Acute Pulmonary Embolism: Systemic Immune-Inflammation Index. Scandinavian Cardiovascular Journal, 55, 91-96. [Google Scholar] [CrossRef] [PubMed]
[40] Libby, P. (2021) The Changing Landscape of Atherosclerosis. Nature, 592, 524-533. [Google Scholar] [CrossRef] [PubMed]
[41] Dong, Y., Zhang, Y., Yang, X., Yan, C. and Feng, Y. (2022) Recent Insights into Neutrophil Extracellular Traps in Cardiovascular Diseases. Journal of Clinical Medicine, 11, Article 6662. [Google Scholar] [CrossRef] [PubMed]
[42] Yang, W., Lin, J., Zhou, J., Zheng, Y., Jiang, S., He, S., et al. (2021) Innate Lymphoid Cells and Myocardial Infarction. Frontiers in Immunology, 12, Article 758272. [Google Scholar] [CrossRef] [PubMed]
[43] Engelbertsen, D. and Lichtman, A.H. (2017) Innate Lymphoid Cells in Atherosclerosis. European Journal of Pharmacology, 816, 32-36. [Google Scholar] [CrossRef] [PubMed]
[44] Meng, L., Yu, Z., Guo, P., Wang, Q., Qi, R., Shan, M., et al. (2018) Neutrophils and Neutrophil-Lymphocyte Ratio: Inflammatory Markers Associated with Intimal-Media Thickness of Atherosclerosis. Thrombosis Research, 170, 45-52. [Google Scholar] [CrossRef] [PubMed]
[45] Balta, S., Celik, T., Mikhailidis, D.P., Ozturk, C., Demirkol, S., Aparci, M., et al. (2015) The Relation between Atherosclerosis and the Neutrophil-Lymphocyte Ratio. Clinical and Applied Thrombosis/Hemostasis, 22, 405-411. [Google Scholar] [CrossRef] [PubMed]
[46] Huilcaman, R., Venturini, W., Fuenzalida, L., Cayo, A., Segovia, R., Valenzuela, C., et al. (2022) Platelets, a Key Cell in Inflammation and Atherosclerosis Progression. Cells, 11, Article 1014. [Google Scholar] [CrossRef] [PubMed]
[47] Sadowski, M., Ząbczyk, M. and Undas, A. (2014) Coronary Thrombus Composition: Links with Inflammation, Platelet and Endothelial Markers. Atherosclerosis, 237, 555-561. [Google Scholar] [CrossRef] [PubMed]
[48] Hsieh, J.Y., Smith, T.D., Meli, V.S., Tran, T.N., Botvinick, E.L. and Liu, W.F. (2017) Differential Regulation of Macrophage Inflammatory Activation by Fibrin and Fibrinogen. Acta Biomaterialia, 47, 14-24. [Google Scholar] [CrossRef] [PubMed]
[49] Landers, C.T., Tung, H., Knight, J.M., Madison, M.C., Wu, Y., Zeng, Z., et al. (2019) Selective Cleavage of Fibrinogen by Diverse Proteinases Initiates Innate Allergic and Antifungal Immunity through CD11b. Journal of Biological Chemistry, 294, 8834-8847. [Google Scholar] [CrossRef] [PubMed]
[50] Davalos, D. and Akassoglou, K. (2011) Fibrinogen as a Key Regulator of Inflammation in Disease. Seminars in Immunopathology, 34, 43-62. [Google Scholar] [CrossRef] [PubMed]
[51] Li, Y., Hirayasu, K., Hasegawa, G., Tomita, Y., Hashikawa, Y., Hiwa, R., et al. (2024) Fibrinogen Induces Inflammatory Responses via the Immune Activating Receptor Lilra2. Frontiers in Immunology, 15. [Google Scholar] [CrossRef] [PubMed]
[52] 张宜帆, 周曼丽, 罗晓欣, 等. 纤维蛋白原与冠心病的相关性[J]. 中国动脉硬化杂志, 2022, 30(5): 431-436.
[53] 何斌. 纤维蛋白原、D2聚体水平与冠心病冠脉病变严重程度的相关性研究[D]: [硕士学位论文]. 百色: 右江民族医学院, 2020.
[54] 闫玉峰, 徐海梅, 赵莹莹, 等. 纤维蛋白原/白蛋白比值预测急性ST段抬高型心肌梗死患者长期预后的临床研究[J]. 岭南心血管病杂志, 2024, 30(3): 237-242.
[55] 杨涛, 孙雪, 杨利梅. CK-MB、FAR、D-二聚体联合检测在老年急性心肌梗死中的临床价值[J]. 分子诊断与治疗杂志, 2024, 16(7): 1268-1271+1280.
[56] 陈雅芳, 李娇, 李思, 等. 红细胞分布宽度和纤维蛋白原与白蛋白比值对冠状动脉疾病严重程度的预测价值分析[J]. 中华老年心脑血管病杂志, 2024, 26(6): 647-652.